Merck ready to quickly deploy Covid antiviral pill if it gets regulatory approval, CEO says
Merck CEO Robert Davis told CNBC on Thursday the drugmaker is ready to produce and distribute tens of millions of doses of its Covid antiviral pills if given regulatory approval."Right now, we're on pace to have 10 million courses ready…